These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 26919826)

  • 1. Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.
    Marshall BD; Green TC; Yedinak JL; Hadland SE
    Int J Drug Policy; 2016 May; 31():25-31. PubMed ID: 26919826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors for Opioid-Use Disorder and Overdose.
    Webster LR
    Anesth Analg; 2017 Nov; 125(5):1741-1748. PubMed ID: 29049118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of benzodiazepine use and misuse among young adults who use prescription opioids non-medically.
    Bouvier BA; Waye KM; Elston B; Hadland SE; Green TC; Marshall BDL
    Drug Alcohol Depend; 2018 Feb; 183():73-77. PubMed ID: 29241103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. America's Opioid Epidemic: Supply and Demand Considerations.
    Clark DJ; Schumacher MA
    Anesth Analg; 2017 Nov; 125(5):1667-1674. PubMed ID: 29049112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating an Epidemic of Prescription Opioid Abuse.
    Pon D; Awuah K; Curi D; Okyere E; Stern CS
    J Calif Dent Assoc; 2015 Nov; 43(11):673-8. PubMed ID: 26798885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with knowledge of a Good Samaritan Law among young adults who use prescription opioids non-medically.
    Evans TI; Hadland SE; Clark MA; Green TC; Marshall BD
    Harm Reduct J; 2016 Jul; 13(1):24. PubMed ID: 27455957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription opioid misuse in the United States and the United Kingdom: cautionary lessons.
    Weisberg DF; Becker WC; Fiellin DA; Stannard C
    Int J Drug Policy; 2014 Nov; 25(6):1124-30. PubMed ID: 25190034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription opioid misuse among adolescents and emerging adults in the United States: A scoping review.
    Bonar EE; Coughlin L; Roche JS; Philyaw-Kotov ML; Bixler EA; Sinelnikov S; Kolosh A; Cihak MJ; Cunningham RM; Walton MA
    Prev Med; 2020 Mar; 132():105972. PubMed ID: 31904397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical Opioids in the Home and Youth: Implications for Adult Medical Practice.
    Binswanger IA; Glanz JM
    Subst Abus; 2015; 36(2):141-3. PubMed ID: 25671706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Can Geographical Information Systems and Spatial Analysis Inform a Response to Prescription Opioid Misuse? A Discussion in the Context of Existing Literature.
    Mazumdar S; Mcrae IS; Islam MM
    Curr Drug Abuse Rev; 2015; 8(2):104-10. PubMed ID: 26452451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic.
    McGinty EE; Barry CL; Stone EM; Niederdeppe J; Kennedy-Hendricks A; Linden S; Sherman SG
    Prev Med; 2018 Jun; 111():73-77. PubMed ID: 29481827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?
    Fischer B; Keates A; Bühringer G; Reimer J; Rehm J
    Addiction; 2014 Feb; 109(2):177-81. PubMed ID: 23692335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010.
    Jones CM
    Drug Alcohol Depend; 2013 Sep; 132(1-2):95-100. PubMed ID: 23410617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription opioid medication misuse among university students.
    Harries MD; Lust K; Christenson GA; Redden SA; Grant JE
    Am J Addict; 2018 Dec; 27(8):618-624. PubMed ID: 30328218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of cannabis in response to the opioid crisis: A review of the literature.
    Vyas MB; LeBaron VT; Gilson AM
    Nurs Outlook; 2018; 66(1):56-65. PubMed ID: 28993073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription-, Illicit-, and Self-Harm Opioid Overdose Cases Treated in Hospital.
    Conner KR; Wiegand TJ; Kaukeinen K; Gorodetsky R; Schult R; Heavey SC
    J Stud Alcohol Drugs; 2018 Nov; 79(6):893-898. PubMed ID: 30573020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.